Orasure Technologies Inc. OSUR

NAS: OSUR | ISIN: US68554V1089 14/07/2025

3,070 USD (-0,97%)

(-0,97%) 14/07/2025

Grafiek Orasure Technologies Inc.

Grafiek Orasure Technologies Inc.

1 dag1d -0,97%
1 week1w 0,99%
1 maand1m 6,60%
3 maanden3m 4,78%
6 maanden6m -18,35%
1 jaar1j -28,60%
5 jaar5j -79,12%

Orasure Technologies Inc. in het nieuws

Toon enkel gratis nieuws

8 juni 2024 · KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 · Persbericht

25 januari 2022 · OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe · Persbericht

1 maart 2021 · OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update · Persbericht

24 februari 2021 · OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference · Persbericht

18 februari 2021 · 2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET · Persbericht

29 januari 2021 · OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test · Persbericht

28 januari 2021 · OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing · Persbericht

21 januari 2021 · OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencing Platform · Persbericht

8 januari 2021 · OraSure Technologies Announces 2021 Annual Meeting Date · Persbericht

5 januari 2021 · OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Profiel Orasure Technologies Inc.

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.orasure.com

Hoofdzetel: Bethlehem, Pennsylvania Verenigde Staten

CEO: Douglas Michels

Werknemers: 470

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe